Literature DB >> 17136396

Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.

Haijun Chen1, Christian von Hehn, Leonard K Kaczmarek, Laura R Ment, Barbara R Pober, Fuki M Hisama.   

Abstract

Myokymia is characterized by spontaneous, involuntary muscle fiber group contraction visible as vermiform movement of the overlying skin. Myokymia with episodic ataxia is a rare, autosomal dominant trait caused by mutations in KCNA1, encoding a voltage-gated potassium channel. In the present study, we report a family with four members affected with myokymia. Additional clinical features included motor delay initially diagnosed as cerebral palsy, worsening with febrile illness, persistent extensor plantar reflex, and absence of epilepsy or episodic ataxia. Mutation analysis revealed a novel c.676C>A substitution in the potassium channel gene KCNA1, resulting in a T226K nonconservative missense mutation in the Kv1.1 subunit in all affected individuals. Electrophysiological studies of the mutant channel expressed in Xenopus oocytes indicated a loss of function. Co-expression of WT and mutant cRNAs significantly reduced whole-oocyte current compared to expression of WT Kv1.1 alone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17136396      PMCID: PMC1820748          DOI: 10.1007/s10048-006-0071-z

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  17 in total

Review 1.  Non-conducting functions of voltage-gated ion channels.

Authors:  Leonard K Kaczmarek
Journal:  Nat Rev Neurosci       Date:  2006-10       Impact factor: 34.870

2.  Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.

Authors:  Steven Vernino; Vanda A Lennon
Journal:  Muscle Nerve       Date:  2002-11       Impact factor: 3.217

3.  Evidence of altered inhibition in layer V pyramidal neurons from neocortex of Kcna1-null mice.

Authors:  J F van Brederode; J M Rho; R Cerne; B L Tempel; W J Spain
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  Episodic ataxia and myokymia syndrome: a new mutation of potassium channel gene Kv1.1.

Authors:  S Comu; M Giuliani; V Narayanan
Journal:  Ann Neurol       Date:  1996-10       Impact factor: 10.422

Review 5.  Developmental seizure susceptibility of kv1.1 potassium channel knockout mice.

Authors:  J M Rho; P Szot; B L Tempel; P A Schwartzkroin
Journal:  Dev Neurosci       Date:  1999-11       Impact factor: 2.984

6.  Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel.

Authors:  K Dedek; B Kunath; C Kananura; U Reuner; T J Jentsch; O K Steinlein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

7.  Hereditary myokymia and periodic ataxia.

Authors:  D H VanDyke; R C Griggs; M J Murphy; M N Goldstein
Journal:  J Neurol Sci       Date:  1975-05       Impact factor: 3.181

8.  Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia.

Authors:  M Kinali; H Jungbluth; L H Eunson; C A Sewry; A Y Manzur; E Mercuri; M G Hanna; F Muntoni
Journal:  Neuromuscul Disord       Date:  2004-10       Impact factor: 4.296

9.  Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.

Authors:  D L Browne; S T Gancher; J G Nutt; E R Brunt; E A Smith; P Kramer; M Litt
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

10.  Episodic ataxia type 1 with distal weakness: a novel manifestation of a potassium channelopathy.

Authors:  A Klein; E Boltshauser; J Jen; R W Baloh
Journal:  Neuropediatrics       Date:  2004-04       Impact factor: 1.947

View more
  13 in total

1.  Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release.

Authors:  Joost H Heeroma; Christian Henneberger; Sanjeev Rajakulendran; Michael G Hanna; Stephanie Schorge; Dimitri M Kullmann
Journal:  Dis Model Mech       Date:  2009-09-24       Impact factor: 5.758

2.  Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia.

Authors:  Jenny van der Wijst; Bob Glaudemans; Hanka Venselaar; Anil V Nair; Anna-Lena Forst; Joost G J Hoenderop; René J M Bindels
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

3.  Familial dyskinesia and facial myokymia (FDFM): Follow-up of a large family and linkage to chromosome 3p21-3q21.

Authors:  Wendy H Raskind; Mark Matsushita; Beate Peter; Jeffrey Biberston; John Wolff; Hillary Lipe; Ruben Burbank; Thomas D Bird
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

4.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

5.  Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.

Authors:  Rían W Manville; Geoffrey W Abbott
Journal:  J Pharmacol Exp Ther       Date:  2020-03-26       Impact factor: 4.030

6.  Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.

Authors:  Susan E Tomlinson; S Veronica Tan; Dimitri M Kullmann; Robert C Griggs; David Burke; Michael G Hanna; Hugh Bostock
Journal:  Brain       Date:  2010-11-23       Impact factor: 13.501

Review 7.  Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

Authors:  Kelsey Paulhus; Lauren Ammerman; Edward Glasscock
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

Review 8.  Paroxysmal motor disorders: expanding phenotypes lead to coalescing genotypes.

Authors:  Laura Zima; Sophia Ceulemans; Gail Reiner; Serena Galosi; Dillon Chen; Michelle Sahagian; Richard H Haas; Keith Hyland; Jennifer Friedman
Journal:  Ann Clin Transl Neurol       Date:  2018-07-17       Impact factor: 4.511

9.  Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.

Authors:  Tracey D Graves; Yoon-Hee Cha; Angelika F Hahn; Richard Barohn; Mohammed K Salajegheh; Robert C Griggs; Brian N Bundy; Joanna C Jen; Robert W Baloh; Michael G Hanna
Journal:  Brain       Date:  2014-02-26       Impact factor: 13.501

Review 10.  New insights into the pathogenesis and therapeutics of episodic ataxia type 1.

Authors:  Maria Cristina D'Adamo; Sonia Hasan; Luca Guglielmi; Ilenio Servettini; Marta Cenciarini; Luigi Catacuzzeno; Fabio Franciolini
Journal:  Front Cell Neurosci       Date:  2015-08-19       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.